CPH
Physician Daily · Monday, August 24, 2026
Newsletters Sign in ON AIR
CrosspointHealthNEWS + REFERENCE LIBRARY
Diagnosis Sheet Anxiety Disorders DSM-5-TR 300.22 | ICD-10-CM F40.00

Agoraphobia

Fear of situations where escape may be difficult or help unavailable if panic-like or incapacitating symptoms occur.

12-month prevalence~1.7% (US adults)
Typical onsetLate teens to mid-30s
Sex ratio2:1 female:male
CoursePersistent; can be housebound

Clinical picture

  • Avoidance spans public transportation, open spaces, enclosed spaces, standing in line or in crowds, and being outside the home alone.
  • Patients map the world by escape routes: aisle seats, positions near exits, short checkout lines, and roads with frequent turnoffs.
  • A trusted companion often makes otherwise impossible outings tolerable, which masks true severity from family and from clinicians.
  • Feared outcomes include panic, falling, incontinence, vomiting, or fainting in public with no one available to help or intervene.
  • Progressive constriction of range can end in housebound status, which a substantial minority of severe untreated cases eventually reach.
  • Employment, medical appointments, and caregiving collapse first, so referral frequently arrives through family or a primary care visit.

Criteria snapshot

  • Marked fear or anxiety about at least two of five situations: public transport, open spaces, enclosed spaces, lines or crowds, and being alone outside.
  • The person fears these settings because escape might be difficult or help unavailable if panic-like or embarrassing symptoms develop.
  • Situations almost always provoke fear, require a companion, or are avoided outright, and the fear is disproportionate to actual danger.
  • Persistent for six months or more, with clinically significant distress or impairment in social and occupational functioning.
  • Now a standalone DSM-5-TR diagnosis; code both agoraphobia and panic disorder when full criteria for each are independently met.

Neurobiology

  • Shares the amygdala, insula, and brainstem fear circuitry of panic disorder, with added hippocampal contextual encoding of specific places.
  • Insular interoceptive prediction error signaling binds body sensations to spatial context, generating situation-specific threat expectancies.
  • Heritability is estimated near 50-60%, higher than most anxiety disorders, with substantial genetic overlap with panic disorder.
  • Vestibular abnormalities and visual dependence are overrepresented and contribute to space and motion discomfort in wide open areas.
  • Chronic HPA axis activation, deconditioning from inactivity, and disrupted circadian light exposure compound physical decline over time.
  • Neuroimaging shows deficient ventromedial prefrontal extinction signaling, matching the poor generalization of safety learning seen clinically.

Psychology

  • Classical conditioning of place cues to panic, followed by operant maintenance through escape and avoidance that terminate anxiety immediately.
  • Fear of fear plus low perceived self-efficacy for coping away from home drives steady generalization to new locations and situations.
  • Safety signals such as a companion, phone, water bottle, or pill bottle preserve the belief that catastrophe was averted only by their presence.
  • Interpersonal reinforcement is common: partners who accompany the patient or run every errand unintentionally sustain the avoidance.
  • Attachment insecurity and early separation experiences increase reliance on proximity to a safe person as the primary emotion regulator.

Differential & comorbidity

  • Differentiate from specific phobia (a single situation), social anxiety (evaluation), PTSD (trauma cues), and depression-related withdrawal.
  • Rule out vestibular disease, orthostatic hypotension, cardiac syncope, and epilepsy before attributing situational avoidance to anxiety alone.
  • Panic disorder co-occurs in a large majority of cases, with major depression and alcohol use disorder following closely behind.
  • Housebound patients show high rates of vitamin D deficiency, physical deconditioning, and untreated chronic medical conditions.
  • Suicidal ideation rises with the duration and severity of confinement, so ask directly even when the presentation looks purely phobic.

Pharmacologic treatment

  • SSRIs are first-line, mirroring panic disorder: sertraline 25-200 mg/day or escitalopram 5-20 mg/day, titrated slowly from a low start.
  • Venlafaxine XR 75-225 mg/day is an appropriate alternative when SSRI response remains inadequate after 8-12 weeks at target dose.
  • Medication reduces panic frequency more reliably than it reduces avoidance, so exposure remains necessary to reclaim daily function.
  • Benzodiazepines taken situationally before outings quickly become safety behaviors and blunt the extinction learning exposure depends on.
  • Continue an effective medication for at least 12 months after remission, then taper across months to limit relapse and rebound.

Psychotherapy

  • In-vivo exposure to feared locations conducted without companions or safety objects is the definitive intervention for agoraphobia.
  • CBT over 12-20 sessions with hierarchy construction, cognitive work, and therapist-accompanied field trips is the standard protocol.
  • Fading the companion and the carried safety object explicitly, step by step, produces the largest gains in real-world functioning.
  • Virtual reality exposure and app-guided field exposure help initiate treatment for patients who are already largely housebound.
  • Home-based and telehealth-delivered exposure programs reach patients who cannot physically attend a clinic to begin treatment at all.

Adjunct options

  • Enlist family to stop accommodating and convert the driving partner into an exposure coach working from a written, agreed plan.
  • Track weekly with the Mobility Inventory for Agoraphobia plus a simple log of independent trips taken and distance traveled.
  • Rebuild physical conditioning gradually, since deconditioned patients misread exertional tachycardia as the onset of another attack.
  • Address the backlog of vitamin D, dental, and preventive care created by years of avoiding appointments outside the home.
  • Escalate to intensive outpatient or home-visit programs when housebound status persists despite an adequate course of outpatient CBT.

Clinical pearls

  • Agoraphobia stands alone in DSM-5-TR; diagnose it separately even when panic disorder is present.
  • Ask who comes with you and what you carry; both answers name the safety behaviors to fade first.
  • Medication reduces panic but rarely restores mobility; exposure is what gives the world back.

References

  • American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
  • Bandelow, B., Michaelis, S., & Wedekind, D. (2017). Treatment of anxiety disorders. Dialogues in Clinical Neuroscience, 19(2), 93-107. https://doi.org/10.31887/DCNS.2017.19.2/bbandelow
  • Craske, M. G., & Stein, M. B. (2016). Anxiety. The Lancet, 388(10063), 3048-3059. https://doi.org/10.1016/S0140-6736(16)30381-6
  • National Institute for Health and Care Excellence. (2020). Generalised anxiety disorder and panic disorder in adults: Management (NICE Guideline CG113). https://www.nice.org.uk/guidance/cg113
  • National Institute of Mental Health. (n.d.). Anxiety disorders. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/topics/anxiety-disorders
  • Roy-Byrne, P. P., Craske, M. G., & Stein, M. B. (2006). Panic disorder. The Lancet, 368(9540), 1023-1032. https://doi.org/10.1016/S0140-6736(06)69418-X
  • Sadock, B. J., Sadock, V. A., & Ruiz, P. (2021). Kaplan & Sadock's synopsis of psychiatry (12th ed.). Wolters Kluwer.
  • Stahl, S. M. (2021). Stahl's essential psychopharmacology (5th ed.). Cambridge University Press.